| 发明名称 |
MODIFIED H7 HEMAGLUTTININ GLYCOPROTEIN OF THE INFLUENZA A/SHANGHAI/2/2013 H7 SEQUENCE |
| 摘要 |
The present invention is directed to a sequence modification of the H7 hemagglutinin glycoprotein of the Influenza A/Shanghai/2/2013 H7 sequence together with vaccines derived therefrom. In addition, the invention further comprises method for improving the efficacy of vaccine antigens by modifying T cell epitopes. |
| 申请公布号 |
WO2016179099(A1) |
申请公布日期 |
2016.11.10 |
| 申请号 |
WO2016US30425 |
申请日期 |
2016.05.02 |
| 申请人 |
EPIVAX, INC. |
发明人 |
DE GROOT, Anne S.;MARTIN, William D. |
| 分类号 |
A61K38/21;A61K31/713;C12Q1/70 |
主分类号 |
A61K38/21 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
